Skip to main navigation
Apexigen, Inc. Logo

Press Releases

Date Title View
June 3, 2023
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
May 24, 2023
Pyxis Oncology to Acquire Apexigen
February 27, 2023
Apexigen Announces Review of Strategic Alternatives and Restructuring
January 24, 2023
Apexigen Announces Approximately $2.8 Million Private Placement Financing
January 19, 2023
Apexigen Announces New Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, at ASCO Gastrointestinal Cancers Symposium 2023
  • Investors Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Financial Information
    • SEC Filings
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact Us
Print Page
Email Alerts
RSS Feeds
Investor Contact
  • Home
  • About
  • Pipeline
  • Science
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Governance Documents
      • Committee Charters
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • Contact
  • Terms of Use
  • About
  • Pipeline
  • Science
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Governance Documents
      • Committee Charters
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • Contact
  • Apexigen, Inc. Logo
© 2022 Apexigen, Inc.All rights reserved
  • Terms of Use
Website Design: Hane Chow, Inc.